Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2025 ▲▼ | Q1 2026 ▲▼ | Change ▲▼ | Q4 2025 ▲▼ | Q1 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Mineralys Therapeutics, Inc.(MLYS) | 7,903,838 | 7,903,838 | 0 | $286.83M | $214.11M | 92.81% | -$72.72M |
| Phathom Pharmaceuticals, Inc.(PHAT) | 1,429,014 | 1,493,854 | +64,840 | $23.71M | $16.60M | 7.19% | -$7.11M |